Global Center for Health Innovation and Accenture Form a Working Group to Address Opioid Epidemic

Executive Briefing Series convenes executives to discuss data-driven solutions to opioid epidemic

CLEVELAND--()--The Global Center for Health Innovation (Global Center) and Accenture have formed a working group to explore data-driven solutions that better integrate the continuum of addiction services (first responders, ER and inpatient, outpatient, behavioral health) to improve treatment and move toward prevention. The group’s formation was announced at the Global Center’s second Executive Briefing, The Role of Private Capital in Attacking the Opioid Crisis.

The working group will collaborate with key stakeholders to recommend a set of actions and a technology platform to enhance the effectiveness of community services, with the goal of national distribution and contributing to reversing the unprecedented rate of addiction and related deaths.

I am pleased to announce the Global Center and Accenture will launch a working group to address the opioid epidemic,” said Aram Nerpouni, president and CEO, BioEnterprise. “Accenture is a thought-leader in this field, and with their guidance, the working group will integrate clinical and community data sources to drive evidence-based changes to our community, opioid addiction programs and services.”

More than 50 industry experts gathered at the Global Center for Health Innovation yesterday for the Executive Briefing. Led by BioEnterprise with Accenture, G2G Consulting, and HIMSS, the briefing provided a unique opportunity for government officials, industry leaders, and innovators to convene and advance discussion of initiatives that move toward prevention and the curtailing of opioid abuse across the nation.

Michael Petersen, M.D., who leads epidemic solutions for Accenture, delivered the Executive Briefing keynote and gave an overview of a global survey of data-driven pilots and solutions that address the opioid crisis.

The issue warrants a multifaceted approach that taps into the collective impact of health, government and community organizations coming together as one,” Dr. Petersen said. “Our working group will explore how to collaborate across data silos, operationalize actionable changes and deploy appropriate resources at every level to make the greatest impact to people’s lives and the communities in which they live.”

Other Briefing participants represented include: The offices of Senators Sherrod Brown and Rob Portman, and Attorney General Mike Dewine; Ohio Development Services Agency; Ohio Third Frontier; The Northeast Ohio Hospital Opioid Consortium (Cleveland Clinic, MetroHealth, Northeast Ohio VA Healthcare System, St. Vincent’s Charity Medical Center and University Hospitals); Surescripts; Appriss Health; Groups Recover Together; Self Refind; Robert Wood Johnson Foundation; Health Velocity Capital; Cordata; Axial Healthcare; and The Dalton Foundation.

About the Global Center for Health Innovation Executive Briefing Series

The Global Center for Health Innovation Executive Briefing Series, presented by BioEnterprise, provides senior thought leaders from industry, venture capital, and private equity, and their portfolio company executives the opportunity to convene and interact in closed sessions. This platform affords participants a unique opportunity for access and open discussion around the opportunities and challenges in achieving the vision of healthcare transformation.

About the Global Center for Health Innovation

Located in Cleveland, the Global Center for Health Innovation (Global Center) is the platform where global healthcare leaders – industry, health systems, investors, and innovators – convene and collaborate to develop solutions to solve high-priority healthcare issues. Engaged brands include BioEnterprise, Cardinal Health, Case Western Reserve University, Cleveland Clinic, DHG Healthcare, G2G Consulting, GE Healthcare, Gleeson, HIMSS, Innovation Fund Northeast Ohio, JumpStart, MetroHealth System, OnBase by Hyland, NGP Capital, Philips Medical, Plug and Play, RiverVest Ventures, RRE Ventures, Siemens, SmartShape, Steris, TeamNEO, University Hospitals System and multiple digital health, medical device and biotechnology startups.

Connected to the Huntington Convention Center and the Hilton Hotel, the Global Center is overseen by the Cuyahoga Country Convention Facilities Development Corporation (CCCFDC) and strategically led by BioEnterprise. The facility is managed by SMG. For more information: www.theglobalcenter.com.

About Accenture

Accenture is a leading global professional services company, providing a broad range of services and solutions in strategy, consulting, digital, technology and operations. Combining unmatched experience and specialized skills across more than 40 industries and all business functions – underpinned by the world’s largest delivery network – Accenture works at the intersection of business and technology to help clients improve their performance and create sustainable value for their stakeholders. With approximately 442,000 people serving clients in more than 120 countries, Accenture drives innovation to improve the way the world works and lives. Visit us at www.accenture.com.

Contacts

Global Center
Annette Ballou, 216-469-9337 (mobile)
aballou@bioenterprise.com
or
Accenture
Jenn Francis, 630-338-6426 (mobile)
jennifer.francis@accenture.com

Release Summary

The Global Center and Accenture form a working group to explore data-driven solutions to integrate opioid addiction services and improve treatment.

Contacts

Global Center
Annette Ballou, 216-469-9337 (mobile)
aballou@bioenterprise.com
or
Accenture
Jenn Francis, 630-338-6426 (mobile)
jennifer.francis@accenture.com